TY - JOUR A1 - Estévez, César A. A1 - Isasi, José Ramón A1 - Larrañeta, Eneko A1 - Vélaz, Itziar T1 - Release of β-galactosidase from poloxamine/α-cyclodextrin hydrogels JF - Beilstein Journal of Organic Chemistry PY - 2014/// VL - 10 SP - 3127 EP - 3135 SN - 1860-5397 DO - 10.3762/bjoc.10.330 PB - Beilstein-Institut JA - Beilstein J. Org. Chem. UR - https://doi.org/10.3762/bjoc.10.330 KW - controlled release KW - cyclodextrins KW - lactase KW - polypseudorotaxane KW - supramolecular gel N2 - All mammals lose their ability to produce lactase (β-galactosidase), the enzyme that cleaves lactose into galactose and glucose, after weaning. The prevalence of lactase deficiency (LD) spans from 2 to 15% among northern Europeans, to nearly 100% among Asians. Following lactose consumption, people with LD often experience gastrointestinal symptoms such as abdominal pain, bowel distension, cramps and flatulence, or even systemic problems such as headache, loss of concentration and muscle pain. These symptoms vary depending on the amount of lactose ingested, type of food and degree of intolerance. Although those affected can avoid the uptake of dairy products, in doing so, they lose a readily available source of calcium and protein. In this work, gels obtained by complexation of Tetronic 90R4 with α-cyclodextrin loaded with β-galactosidase are proposed as a way to administer the enzyme immediately before or with the lactose-containing meal. Both molecules are biocompatible, can form gels in situ, and show sustained erosion kinetics in aqueous media. The complex was characterized by FTIR that evidenced an inclusion complex between the polyethylene oxide block and α-cyclodextrin. The release profiles of β-galactosidase from two different matrices (gels and tablets) of the in situ hydrogels have been obtained. The influence of the percentage of Tetronic in media of different pH was evaluated. No differences were observed regarding the release rate from the gel matrices at pH 6 (t50 = 105 min). However, in the case of the tablets, the kinetics were faster and they released a greater amount of 90R4 (25%, t50 = 40–50 min). Also, the amount of enzyme released was higher for mixtures with 25% Tetronic. Using suitable mathematical models, the corresponding kinetic parameters have been calculated. In all cases, the release data fit quite well to the Peppas–Sahlin model equation, indicating that the release of β-galactosidase is governed by a combination of diffusion and erosion processes. It has been observed that the diffusion mechanism prevails over erosion during the first 50 minutes, followed by continued release of the enzyme due to the disintegration of the matrix. ER - TY - JOUR AU - Alliende, F. G. JF - Gastroenterol. Latinoam. PY - 2007/// VL - 18 SP - 152 EP - 156 ER - TY - JOUR AU - Ratzinger, G. AU - Wang, X. AU - Wirth, M. AU - Gabor, F. JF - J. Controlled Release PY - 2010/// VL - 147 SP - 187 EP - 192 DO - 10.1016/j.jconrel.2010.04.017 ER - TY - JOUR AU - Squillante, E. AU - Morshed, G. AU - Bagchi, S. AU - Mehta, K. A. JF - J. Microencapsulation PY - 2003/// VL - 20 SP - 153 EP - 167 DO - 10.3109/02652040309178058 ER - TY - ELEC AU - Hensley, A. L. T1 - The enzyme β-galactosidase: structure and function UR - http://chemistry.berea.edu/~biochemistry/2008/ah ER - TY - THES AU - Benevides, C. T1 - Ingeniería de biocatalizadores y bioprocesos: beta-galactosidasa de Thermus sp., cepa T2 PY - 2002/// PB - Universidad Politécnica de Madrid CY - Spain ER - TY - JOUR AU - van de Manakker, F. AU - Braeckmans, K. AU - el Morabit, N. AU - De Smedt, S. AU - van Nostrum, C. F. AU - Hennink, W. E. JF - Adv. Funct. Mater. PY - 2009/// VL - 19 SP - 2992 EP - 3001 DO - 10.1002/adfm.200900603 ER - TY - JOUR AU - Soto, D. AU - Oliva, H. JF - Rev. Latinam. Metal. Mat. PY - 2012/// VL - 32 SP - 154 EP - 175 ER - TY - JOUR AU - Fernández-Tarrio, M. AU - Yáñez, F. AU - Immesoete, K. AU - Alvarez-Lorenzo, C. AU - Concheiro, A. JF - AAPS PharmSciTech PY - 2008/// VL - 9 SP - 471 EP - 479 DO - 10.1208/s12249-008-9070-8 ER - TY - JOUR AU - Alvarez-Lorenzo, C. AU - González-López, J. AU - Fernández-Tarrio, M. AU - Sández-Macho, I. AU - Concheiro, A. JF - Eur. J. Pharm. Biopharm. PY - 2007/// VL - 66 SP - 244 EP - 252 DO - 10.1016/j.ejpb.2006.10.010 ER - TY - JOUR AU - Martínez, G. AU - Gómez, M. JF - Rev. Iberoam. Polim. PY - 2007/// VL - 8 SP - 300 EP - 312 ER - TY - JOUR AU - Simões, S. M. N. AU - Veiga, F. AU - Torres-Labandeira, J. J. AU - Ribeiro, A. C. F. AU - Concheiro, A. AU - Alvarez-Lorenzo, C. JF - Macromol. Biosci. PY - 2013/// VL - 13 SP - 723 EP - 734 DO - 10.1002/mabi.201300017 ER - TY - JOUR AU - Tan, S. AU - Ladewig, K. AU - Fu, Q. AU - Blencowe, A. AU - Qiao, G. G. JF - Macromol. Rapid Commun. PY - 2014/// VL - 35 SP - 1166 EP - 1184 DO - 10.1002/marc.201400080 ER - TY - JOUR AU - Larrañeta, E. AU - Isasi, J. R. JF - Langmuir PY - 2012/// VL - 28 SP - 12457 EP - 12462 DO - 10.1021/la3024452 ER - TY - JOUR AU - Chee, P. L. AU - Prasad, A. AU - Fang, X. AU - Owh, C. AU - Yeo, V. J. J. AU - Loh, X. J. JF - Mater. Sci. Eng., C PY - 2014/// VL - 39 SP - 6 EP - 12 DO - 10.1016/j.msec.2014.02.026 ER - TY - JOUR AU - Katime, I. AU - Katime, O. AU - Katime, D. JF - An. R. Soc. Esp. Fis. Quim. PY - 2005/// VL - 4 SP - 35 EP - 50 ER - TY - JOUR AU - Larrañeta, E. AU - Isasi, J. R. JF - Carbohydr. Polym. PY - 2014/// VL - 102 SP - 674 EP - 681 DO - 10.1016/j.carbpol.2013.11.002 ER - TY - JOUR AU - Machín, R. AU - Isasi, J. R. AU - Vélaz, I. JF - Eur. Polym. J. PY - 2013/// VL - 49 SP - 3912 EP - 3920 DO - 10.1016/j.eurpolymj.2013.08.020 ER - TY - JOUR AU - Peppas, N. A. AU - Sahlin, J. J. JF - Int. J. Pharm. PY - 1989/// VL - 57 SP - 169 EP - 172 DO - 10.1016/0378-5173(89)90306-2 ER - TY - JOUR AU - Dash, S. AU - Murthy, P. N. AU - Nath, L. AU - Chowdury, P. JF - Acta Pol. Pharm. PY - 2010/// VL - 67 SP - 217 EP - 223 ER - TY - JOUR AU - Paul, D. R. JF - Int. J. Pharm. PY - 2011/// VL - 418 SP - 13 EP - 17 DO - 10.1016/j.ijpharm.2010.10.037 ER - TY - JOUR AU - Larrañeta, E. AU - Martínez-Ohárriz, C. AU - Vélaz, I. AU - Zornoza, A. AU - Machín, R. AU - Isasi, J. R. JF - J. Pharm. Sci. PY - 2014/// VL - 103 SP - 197 EP - 206 DO - 10.1002/jps.23774 ER - TY - JOUR AU - Mustafi, D. AU - Smith, C. M. AU - Makinen, M. W. AU - Lee, R. C. JF - Biochim. Biophys. Acta PY - 2008/// VL - 1780 SP - 7 EP - 15 DO - 10.1016/j.bbagen.2007.08.017 ER - TY - GEN N1 - USP 37–NF 32. The United States Pharmacopeial Convention; 2014. ER -